IGFBP2 promotes the EMT of colorectal cancer cells by regulating E-cadherin expression

被引：4

作者：

Zhu, Huange ^{[1
]}

Zhang, Yanping ^{[1
]}

Geng, Yan ^{[1
]}

Lu, Wei ^{[1
]}

Yin, Jian ^{[1
]}

Li, Zhenzhen ^{[1
]}

Huang, Lun ^{[1
]}

Liu, Hailong ^{[1
]}

Xu, Nan ^{[1
]}

机构：

[1] Xi An Jiao Tong Univ, Xibei Hosp, Affiliated Hosp 2, Clin Lab, 157 Xiwu Rd, Xian 710004, Shaanxi, Peoples R China

来源：

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2019年 / 12卷 / 07期

关键词：

Colorectal cancer; insulin like growth factor binding protein 2 (IGFBP2); epithelial-mesenchymal transition (EMT); E-cadherin; FACTOR-BINDING PROTEIN-2; GROWTH; GLIOBLASTOMA; PROLIFERATION; BIOMARKER; INVASION; PATHWAY; COLON; RISK;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This study aimed to investigate the expression of insulin like growth factor binding protein 2 (IGFBP2) in colorectal cancer cells and its effect on the biological characteristics of cancer cells. We first established IGFBP2 knockdown (HCT116-shIGFBP2) and overexpression (HT29-IGFBP2) cell lines. Western blotting was used to evaluate the overexpression and knockdown efficiency. Next, the effect of IGFBP2 on colorectal cancer cell proliferation and migration was evaluated through cell proliferation and wound healing assays, respectively. Cell proliferation experiments showed that the upregulation of IGFBP2 promoted the proliferation of HT29 cells, but the downregulation of IGFBP2 inhibited the proliferation of HCT116 cells. Moreover, a wound healing assay showed that the migration ability of HCT116 cells was significantly reduced after the downregulation of IGFBP2. Also, the level of E-cadherin in HCT116-shIGFBP2 cells was significantly upregulated following IGFBP2 knockdown. Further analyses showed that colorectal cancer cells secreted high levels of IGFBP2 into the extracellular matrix, which inhibited E-cadherin expression as well. Overall, the results of this study showed that IGFBP2 inhibits the expression of E-cadherin and promotes the proliferation and migration of colorectal cancer cells.

引用

页码：2559 / 2565

页数：7

共 25 条

[1] Diagnostic value of symptoms for colorectal cancer in primary care: a systematic review [J].

Hamilton, William ;

Astin, Margaret ;

Griffin, Tom ;

Neal, Richard D. ;

Rose, Peter .

BRITISH JOURNAL OF GENERAL PRACTICE, 2011, 61 (586) :e231-e243

[2] Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression [J].

Ben-Shmuel, A. ;

Shvab, A. ;

Gavert, N. ;

Brabletz, T. ;

Ben-Ze'ev, A. .

ONCOGENE, 2013, 32 (27) :3220-3230

[3]

Benson AB, 2007, J MANAGE CARE PHARM, V13, pS5

[4] Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells [J].

Chakrabarty, S ;

Kondratick, L .

CANCER BIOLOGY & THERAPY, 2006, 5 (02) :189-197

[5] Elevated serum insulin-like growth factor binding protein-2 is associated with a high relapse risk after hematopoietic stem cell transplantation in childhood AML [J].

Dawczynski, K ;

Kauf, E ;

Schlenvoigt, D ;

Gruhn, B ;

Fuchs, D ;

Zintl, F .

BONE MARROW TRANSPLANTATION, 2006, 37 (06) :589-594

[6] Cellular actions of the insulin-like growth factor binding proteins [J].

Firth, SM ;

Baxter, RC .

ENDOCRINE REVIEWS, 2002, 23 (06) :824-854

[7] Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) Promotes Growth and Survival of Breast Epithelial Cells: Novel Regulation of the Estrogen Receptor [J].

Foulstone, Emily J. ;

Zeng, Li ;

Perks, Claire M. ;

Holly, Jeff M. P. .

ENDOCRINOLOGY, 2013, 154 (05) :1780-1793

[8] Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway [J].

Han, S. ;

Li, Z. ;

Master, L. M. ;

Master, Z. W. ;

Wu, A. .

BRITISH JOURNAL OF CANCER, 2014, 111 (07) :1400-1409

[9] Deregulation of IGF-binding proteins-2 and-5 contributes to the development of endocrine resistant breast cancer in vitro [J].

Hawsawi, Yousef ;

Humphries, Matthew P. ;

Wright, Alexander ;

Berwick, Angelene ;

Shires, Mike ;

Al-Kharobi, Hanaa ;

El-Gendy, Reem ;

Jove, Maria ;

Twelves, Chris ;

Speirs, Valerie ;

Beattie, James .

ONCOTARGET, 2016, 7 (22) :32129-32143

[10]

Hoeflich A, 2000, CANCER RES, V60, P834

← 1 2 3 →